New Delhi, Nov 23 (PTI) Alembic Pharmaceuticals on Saturday said the US health regulator has issued Form 483 with five observations after inspecting its Gujarat-based manufacturing plant.

The US Food and Drug Administration (USFDA) conducted inspection at Jarod-based solid oral formulation facility from November 14-22, 2024, the drug firm said in a regulatory filing.

Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for November 23, 2024 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game.

The USFDA issued a Form 483 with five procedural observations, it added.

The company will provide a comprehensive response to the USFDA for the observations within the stipulated period, it said.

Also Read | Shillong Teer Results Today, November 23 2024: Winning Numbers, Result Chart for Shillong Morning Teer, Shillong Night Teer, Khanapara Teer, Juwai Teer and Jowai Ladrymbai.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)

sed-plant-6440050.html&text=Latest+News+%7C+Alembic+Gets+5+Observations+from+USFDA+for+Gujarat-based+Plant&via=latestly" title="Tweet">